Publication | Open Access
Evaluation of a Commercial Culture-Free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison With an Antireceptor-Binding Domain Enzyme-Linked Immunosorbent Assay
41
Citations
24
References
2021
Year
The added value of cPass compared with an IgG anti-RBD ELISA was modest.
| Year | Citations | |
|---|---|---|
Page 1
Page 1